Boston Scientific resumes enrolment in pulsed field ablation trial [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
The trial – which tests Boston Scientific's Farapulse technology in patients with atrial fibrillation – was paused to evaluate observations made in early study stages. Boston Scientific's global chief medical officer, Kenneth Stein, said on a 23 October Q3 earnings investor call that the observations were not life-threatening, but he could not provide more details on the ongoing study. Following a detailed review with the data monitoring committee, the company announced that recruitment could safely proceed. The AVANT GUARD trial investigates the safety and efficacy of pulsed field ablation (PFA) as a first-line treatment for persistent atrial fibrillation. Atrial fibrillation, a prevalent heart condition linked to severe health risks, currently has limited treatment options for patients who have not yet been prescribed anti-arrhythmic drugs. “I just want to close by emphasising that the patient population we're studying in AVANT GUARD, which is drug-naive, persistent AF patien
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of DirectorsPR Newswire
- Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain [Yahoo! Finance]Yahoo! Finance
- QGEN Collaborates With McGill University Centre: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- How EHR Data Can be Used to Advance Guideline-directed Care, Upcoming Webinar Hosted by XtalksPR Web
- Dr. Steven Shamah, Director of Endoscopy at Lenox Hill Hospital in New York to Teach Endoscopic Closure Program in Madrid, Spain [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/23/24 - Beat
BSX
Sec Filings
- 11/13/24 - Form 4
- 11/12/24 - Form 4
- 11/8/24 - Form 144
- BSX's page on the SEC website